After getting hammered on Tuesday, the stock market tried to find its footing on Wednesday. But the market isn’t doing a very good job convincing investors that it has bottomed. With that in mind, let’s look at a few top stock trades for Thursday. Top Stock Trades for Tomorrow No. 1: Lucid Motors (LCID) I…

Lightspeed Commerce (NYSE:LSPD) stock is on the rise Wednesday following the release of a short report. Source: Piotr Swat / Shutterstock.com Spruce Point Capital Management is behind the short report hitting LSPD stock today. The investment management firm highlights several reasons that it believes Lightspeed Commerce could see shares fall from 60% to 80%. Let’s…

Today, gene-editing stock Editas Medicine (NASDAQ:EDIT) is seeing impressive selling pressure. Currently, shares of EDIT stock are down 20% on heavy volume as investors continue to re-assess their growth holdings today. Source: Shutterstock Despite a rather nice bounce back for equities following yesterday’s decline, today’s price action across specific stocks has been choppy. Editas has been one…

In the 1980s, the field of genetics surged in popularity. At the time, I’m sure there were many articles promising investors that genetics stocks were on the cusp of spectacular gains. Investors who were looking for short-term payoffs then were disappointed, but now, gene editing stocks look far more promising. Researching the genetic origin behind…

Today, gene editing stocks are once again in focus for investors. Indeed, today’s moves in a number of the most prominent stocks in this space are worth noting. Editas Medicine (NASDAQ:EDIT), Intellia Therapeutics (NASDAQ:NTLA) and CRISPR (NASDAQ:CRSP) are all up between 6% and 17% today. Source: Shutterstock These outsized moves come on a very green day in financial…

For investors interested in gene editing, Crispr Therapeutics (NASDAQ:CRSP) stock is a must-watch. The company’s gene-editing platform promises to deliver therapies across sickle cell disorders, cancer and diabetes, among other diseases.  Source: Shutterstock Yet while CRSP stock does possess massive potential, there are lots of reasons to believe it may never achieve its lofty goals.…

Remember the 2014 Tom Cruise film Edge of Tomorrow? Source: Shutterstock Great flick. If you haven’t seen it and are into science fiction movies, I highly recommend giving it a watch. In any event, the movie centers around Cruise playing a solider who uses a supercharged, futuristic military exoskeleton to help fight off an invading…

When one considers exchange-traded funds, looking for the best ETFs, to buy that will make your world a better place, a fair number of investors immediately gravitate to those funds with an ESG (environmental, social, and governance) bent.  However, for this article, I’ll come at it from a perspective of innovation.  For example, back in…

Editas Medicine (NASDAQ:EDIT) stock represents investment in pioneering CRISPR gene editing medicine. Source: Natali_ Mis/ShutterStock.com It is best to approach a potential investment in Editas Medicine by first understanding the fundamental technology. Biotech is an emerging field, and it’s important to not go into an investment of this sort blindly. Once we understand the underlying…

Gene editing could revolutionize the way we treat diseases. By removing cells from the body, modifying them and reintroducing them, therapies could treat cancers, cystic fibrosis, sickle cell and muscular dystrophy. At some point, perhaps, this could extend to treating all known disease. “While the technology is still fairly new, academic institutes and biopharma companies…

The year is 1950. The month is October. Alan Turing – the generational genius who cracked the Enigma code and helped end World War II – has just introduced a novel concept. It’s called the “Turing Test,” and it is aimed at answering the fundamental question: Can machines think? The world laughs. Machines? Think for…